The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Liposome Drug Delivery Market Research Report 2025

Global Liposome Drug Delivery Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1704648

No of Pages : 95

Ask Your Query

Synopsis

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.

The global Liposome Drug Delivery market was valued at US$ 3734 million in 2023 and is anticipated to reach US$ 8760.1 million by 2030, witnessing a CAGR of 12.8% during the forecast period 2024-2030.

Global Liposome Drug Delivery key players include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, etc. Global top five manufacturers hold a share about 60%. North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both with a share about 30 percent. In terms of product, Liposomal Doxorubicin is the largest segment, with a share about 40%. And in terms of application, the largest application is Cancer & Tumor Therapy, followed by Fungal Infection Therapy, etc.

This report aims to provide a comprehensive presentation of the global market for Liposome Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposome Drug Delivery.

Report Scope

The Liposome Drug Delivery market size, estimations, and forecasts are provided in terms of sales volume (K Vial) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Liposome Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Liposome Drug Delivery manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

  • Gilead Sciences
  • Pacira
  • Sun Pharmaceutical
  • Johnson & Johnson
  • Luye Pharma
  • Sigma-Tau
  • Ipsen (Onivyde)
  • CSPC
  • Teva Pharmaceutical
  • Novartis
  • Fudan-Zhangjiang

Segment by Type

  • Liposomal Doxorubicin
  • Liposomal Amphoteracin B
  • Liposomal Paclitaxel
  • Others

Segment by Application

  • Fungal Infection Therapy
  • Cancer & Tumor Therapy
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Liposome Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Liposome Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Liposome Drug Delivery Market Overview
1.1 Product Overview and Scope of Liposome Drug Delivery
1.2 Liposome Drug Delivery Segment by Type
1.2.1 Global Liposome Drug Delivery Market Value Comparison by Type (2024-2030)
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Liposome Drug Delivery Segment by Application
1.3.1 Global Liposome Drug Delivery Market Value by Application: (2024-2030)
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Global Liposome Drug Delivery Market Size Estimates and Forecasts
1.4.1 Global Liposome Drug Delivery Revenue 2019-2030
1.4.2 Global Liposome Drug Delivery Sales 2019-2030
1.4.3 Global Liposome Drug Delivery Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Liposome Drug Delivery Market Competition by Manufacturers
2.1 Global Liposome Drug Delivery Sales Market Share by Manufacturers (2019-2024)
2.2 Global Liposome Drug Delivery Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Liposome Drug Delivery Average Price by Manufacturers (2019-2024)
2.4 Global Liposome Drug Delivery Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Liposome Drug Delivery, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Liposome Drug Delivery, Product Type & Application
2.7 Liposome Drug Delivery Market Competitive Situation and Trends
2.7.1 Liposome Drug Delivery Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Liposome Drug Delivery Players Market Share by Revenue
2.7.3 Global Liposome Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Liposome Drug Delivery Retrospective Market Scenario by Region
3.1 Global Liposome Drug Delivery Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Liposome Drug Delivery Global Liposome Drug Delivery Sales by Region: 2019-2030
3.2.1 Global Liposome Drug Delivery Sales by Region: 2019-2024
3.2.2 Global Liposome Drug Delivery Sales by Region: 2025-2030
3.3 Global Liposome Drug Delivery Global Liposome Drug Delivery Revenue by Region: 2019-2030
3.3.1 Global Liposome Drug Delivery Revenue by Region: 2019-2024
3.3.2 Global Liposome Drug Delivery Revenue by Region: 2025-2030
3.4 North America Liposome Drug Delivery Market Facts & Figures by Country
3.4.1 North America Liposome Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Liposome Drug Delivery Sales by Country (2019-2030)
3.4.3 North America Liposome Drug Delivery Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Liposome Drug Delivery Market Facts & Figures by Country
3.5.1 Europe Liposome Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Liposome Drug Delivery Sales by Country (2019-2030)
3.5.3 Europe Liposome Drug Delivery Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Liposome Drug Delivery Market Facts & Figures by Country
3.6.1 Asia Pacific Liposome Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Liposome Drug Delivery Sales by Country (2019-2030)
3.6.3 Asia Pacific Liposome Drug Delivery Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Liposome Drug Delivery Market Facts & Figures by Country
3.7.1 Latin America Liposome Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Liposome Drug Delivery Sales by Country (2019-2030)
3.7.3 Latin America Liposome Drug Delivery Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Liposome Drug Delivery Market Facts & Figures by Country
3.8.1 Middle East and Africa Liposome Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Liposome Drug Delivery Sales by Country (2019-2030)
3.8.3 Middle East and Africa Liposome Drug Delivery Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Liposome Drug Delivery Sales by Type (2019-2030)
4.1.1 Global Liposome Drug Delivery Sales by Type (2019-2024)
4.1.2 Global Liposome Drug Delivery Sales by Type (2025-2030)
4.1.3 Global Liposome Drug Delivery Sales Market Share by Type (2019-2030)
4.2 Global Liposome Drug Delivery Revenue by Type (2019-2030)
4.2.1 Global Liposome Drug Delivery Revenue by Type (2019-2024)
4.2.2 Global Liposome Drug Delivery Revenue by Type (2025-2030)
4.2.3 Global Liposome Drug Delivery Revenue Market Share by Type (2019-2030)
4.3 Global Liposome Drug Delivery Price by Type (2019-2030)
5 Segment by Application
5.1 Global Liposome Drug Delivery Sales by Application (2019-2030)
5.1.1 Global Liposome Drug Delivery Sales by Application (2019-2024)
5.1.2 Global Liposome Drug Delivery Sales by Application (2025-2030)
5.1.3 Global Liposome Drug Delivery Sales Market Share by Application (2019-2030)
5.2 Global Liposome Drug Delivery Revenue by Application (2019-2030)
5.2.1 Global Liposome Drug Delivery Revenue by Application (2019-2024)
5.2.2 Global Liposome Drug Delivery Revenue by Application (2025-2030)
5.2.3 Global Liposome Drug Delivery Revenue Market Share by Application (2019-2030)
5.3 Global Liposome Drug Delivery Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Gilead Sciences
6.1.1 Gilead Sciences Corporation Information
6.1.2 Gilead Sciences Description and Business Overview
6.1.3 Gilead Sciences Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Gilead Sciences Liposome Drug Delivery Product Portfolio
6.1.5 Gilead Sciences Recent Developments/Updates
6.2 Pacira
6.2.1 Pacira Corporation Information
6.2.2 Pacira Description and Business Overview
6.2.3 Pacira Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pacira Liposome Drug Delivery Product Portfolio
6.2.5 Pacira Recent Developments/Updates
6.3 Sun Pharmaceutical
6.3.1 Sun Pharmaceutical Corporation Information
6.3.2 Sun Pharmaceutical Description and Business Overview
6.3.3 Sun Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sun Pharmaceutical Liposome Drug Delivery Product Portfolio
6.3.5 Sun Pharmaceutical Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson Liposome Drug Delivery Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Luye Pharma
6.5.1 Luye Pharma Corporation Information
6.5.2 Luye Pharma Description and Business Overview
6.5.3 Luye Pharma Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Luye Pharma Liposome Drug Delivery Product Portfolio
6.5.5 Luye Pharma Recent Developments/Updates
6.6 Sigma-Tau
6.6.1 Sigma-Tau Corporation Information
6.6.2 Sigma-Tau Description and Business Overview
6.6.3 Sigma-Tau Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sigma-Tau Liposome Drug Delivery Product Portfolio
6.6.5 Sigma-Tau Recent Developments/Updates
6.7 Ipsen (Onivyde)
6.6.1 Ipsen (Onivyde) Corporation Information
6.6.2 Ipsen (Onivyde) Description and Business Overview
6.6.3 Ipsen (Onivyde) Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ipsen (Onivyde) Liposome Drug Delivery Product Portfolio
6.7.5 Ipsen (Onivyde) Recent Developments/Updates
6.8 CSPC
6.8.1 CSPC Corporation Information
6.8.2 CSPC Description and Business Overview
6.8.3 CSPC Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CSPC Liposome Drug Delivery Product Portfolio
6.8.5 CSPC Recent Developments/Updates
6.9 Teva Pharmaceutical
6.9.1 Teva Pharmaceutical Corporation Information
6.9.2 Teva Pharmaceutical Description and Business Overview
6.9.3 Teva Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Teva Pharmaceutical Liposome Drug Delivery Product Portfolio
6.9.5 Teva Pharmaceutical Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Corporation Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Novartis Liposome Drug Delivery Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Fudan-Zhangjiang
6.11.1 Fudan-Zhangjiang Corporation Information
6.11.2 Fudan-Zhangjiang Liposome Drug Delivery Description and Business Overview
6.11.3 Fudan-Zhangjiang Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Fudan-Zhangjiang Liposome Drug Delivery Product Portfolio
6.11.5 Fudan-Zhangjiang Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Liposome Drug Delivery Industry Chain Analysis
7.2 Liposome Drug Delivery Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Liposome Drug Delivery Production Mode & Process
7.4 Liposome Drug Delivery Sales and Marketing
7.4.1 Liposome Drug Delivery Sales Channels
7.4.2 Liposome Drug Delivery Distributors
7.5 Liposome Drug Delivery Customers
8 Liposome Drug Delivery Market Dynamics
8.1 Liposome Drug Delivery Industry Trends
8.2 Liposome Drug Delivery Market Drivers
8.3 Liposome Drug Delivery Market Challenges
8.4 Liposome Drug Delivery Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock